{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:40:18Z","timestamp":1756226418296,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04424-5","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T03:39:29Z","timestamp":1756179569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between statin therapy and incident diabetes mellitus in patients with nephrotic syndrome: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yongsheng","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyuan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"4","key":"4424_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.mcna.2023.03.006","volume":"107","author":"MJ Zabala Ramirez","year":"2023","unstructured":"Zabala Ramirez MJ, Stein EJ, Jain K. Nephrotic syndrome for the internist. Med Clin North Am Jul. 2023;107(4):727\u201337. https:\/\/doi.org\/10.1016\/j.mcna.2023.03.006.","journal-title":"Med Clin North Am Jul"},{"issue":"12","key":"4424_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2215\/CJN.07180622","volume":"17","author":"RE Campbell","year":"2022","unstructured":"Campbell RE, Thurman JM. The immune system and idiopathic nephrotic syndrome. Clin J Am Soc Nephrol Dec. 2022;17(12):1823\u201334. https:\/\/doi.org\/10.2215\/CJN.07180622.","journal-title":"Clin J Am Soc Nephrol Dec"},{"issue":"2","key":"4424_CR3","doi-asserted-by":"publisher","first-page":"e53923","DOI":"10.7759\/cureus.53923","volume":"16","author":"PR Verma","year":"2024","unstructured":"Verma PR, Patil P. Nephrotic syndrome: a review. Cureus Feb. 2024;16(2):e53923. https:\/\/doi.org\/10.7759\/cureus.53923.","journal-title":"Cureus Feb"},{"key":"4424_CR4","unstructured":"Tapia C, Bashir K. Nephrotic syndrome. StatPearls. 2025."},{"issue":"1","key":"4424_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol Jan. 2018;14(1):57\u201370. https:\/\/doi.org\/10.1038\/nrneph.2017.155.","journal-title":"Nat Rev Nephrol Jan"},{"issue":"1","key":"4424_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12882-022-03042-9","volume":"3","author":"J Li","year":"2023","unstructured":"Li J, Hui D, Yang L, Hou J, Xie H. Effect of high density lipoprotein cholesterol (HDL-C) on renal outcome in patients with nephrotic syndrome complicated with steroid-induced diabetes mellitus(SIDM). BMC Nephrol Jan. 2023;3(1):2. https:\/\/doi.org\/10.1186\/s12882-022-03042-9.","journal-title":"BMC Nephrol Jan"},{"issue":"12","key":"4424_CR7","doi-asserted-by":"publisher","first-page":"CD005425","DOI":"10.1002\/14651858.CD005425.pub2","volume":"10","author":"X Kong","year":"2013","unstructured":"Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L. Lipid-lowering agents for nephrotic syndrome. Cochrane Database Syst Rev Dec. 2013;10(12):CD005425. https:\/\/doi.org\/10.1002\/14651858.CD005425.pub2.","journal-title":"Cochrane Database Syst Rev Dec"},{"issue":"3","key":"4424_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000330355","volume":"34","author":"RG Kalaitzidis","year":"2011","unstructured":"Kalaitzidis RG, Elisaf MS. The role of statins in chronic kidney disease. Am J Nephrol. 2011;34(3):195\u2013202. https:\/\/doi.org\/10.1159\/000330355.","journal-title":"Am J Nephrol"},{"issue":"10384","key":"4424_CR9","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"15","author":"PM Ridker","year":"2023","unstructured":"Ridker PM, Bhatt DL, Pradhan AD, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving Statin therapy: a collaborative analysis of three randomised trials. Lancet Apr. 2023;15(10384):1293\u2013301. https:\/\/doi.org\/10.1016\/S0140-6736(23)00215-5.","journal-title":"Lancet Apr"},{"issue":"1","key":"4424_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1053\/ajkd.2003.50016","volume":"41","author":"N Ieiri","year":"2003","unstructured":"Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis Jan. 2003;41(1):244\u20139. https:\/\/doi.org\/10.1053\/ajkd.2003.50016.","journal-title":"Am J Kidney Dis Jan"},{"issue":"1","key":"4424_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41467-023-35944-z","volume":"24","author":"TS Huang","year":"2023","unstructured":"Huang TS, Wu T, Wu YD, et al. Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice. Nat Commun Jan. 2023;24(1):390. https:\/\/doi.org\/10.1038\/s41467-023-35944-z.","journal-title":"Nat Commun Jan"},{"issue":"1","key":"4424_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11883-024-01266-8","volume":"19","author":"CL Bredefeld","year":"2024","unstructured":"Bredefeld CL, Choi P, Cullen T, Nicolich-Henkin SJ, Waters L. Statin use and hyperglycemia: do Statins cause diabetes?? Curr Atheroscler Rep Dec. 2024;19(1):18. https:\/\/doi.org\/10.1007\/s11883-024-01266-8.","journal-title":"Curr Atheroscler Rep Dec"},{"issue":"5","key":"4424_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","volume":"12","author":"Cholesterol Treatment Trialists\u2019 Collaboration","year":"2024","unstructured":"Cholesterol Treatment Trialists\u2019 Collaboration. Electronic address cnoau, cholesterol treatment trialists C. Effects of Statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded Statin trials: an individual participant data meta-analysis. Lancet Diabetes Endocrinol May. 2024;12(5):306\u201319. https:\/\/doi.org\/10.1016\/S2213-8587(24)00040-8.","journal-title":"Lancet Diabetes Endocrinol May"},{"issue":"9","key":"4424_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"5","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med May. 2009;5(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med May"},{"issue":"12","key":"4424_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3949\/ccjm.79a.12091","volume":"79","author":"MB Rocco","year":"2012","unstructured":"Rocco MB. Statins and diabetes risk: fact, fiction, and clinical implications. Cleve Clin J Med Dec. 2012;79(12):883\u201393. https:\/\/doi.org\/10.3949\/ccjm.79a.12091.","journal-title":"Cleve Clin J Med Dec"},{"issue":"9716","key":"4424_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"27","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised Statin trials. Lancet Feb. 2010;27(9716):735\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(09)61965-6.","journal-title":"Lancet Feb"},{"issue":"5","key":"4424_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","volume":"58","author":"H Cederberg","year":"2015","unstructured":"Cederberg H, Stancakova A, Yaluri N, Modi S, Kuusisto J, Laakso M. Increased risk of diabetes with Statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort. Diabetologia May. 2015;58(5):1109\u201317. https:\/\/doi.org\/10.1007\/s00125-015-3528-5.","journal-title":"Diabetologia May"},{"issue":"4","key":"4424_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00125-012-2817-5","volume":"56","author":"N Sattar","year":"2013","unstructured":"Sattar N. Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia Apr. 2013;56(4):686\u201395. https:\/\/doi.org\/10.1007\/s00125-012-2817-5.","journal-title":"Diabetologia Apr"},{"issue":"6","key":"4424_CR19","doi-asserted-by":"publisher","first-page":"e2112820","DOI":"10.1001\/jamanetworkopen.2021.12820","volume":"1","author":"G Liu","year":"2021","unstructured":"Liu G, Shi M, Mosley JD, et al. A Mendelian randomization approach using 3-HMG-Coenzyme-A reductase gene variation to evaluate the association of Statin-Induced Low-Density lipoprotein cholesterol Lowering with noncardiovascular disease phenotypes. JAMA Netw Open Jun. 2021;1(6):e2112820. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.12820.","journal-title":"JAMA Netw Open Jun"},{"issue":"Suppl 2","key":"4424_CR20","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.2337\/dc09-S344","volume":"32","author":"Y Kamari","year":"2009","unstructured":"Kamari Y, Bitzur R, Cohen H, Shaish A, Harats D. Should all diabetic patients be treated with a statin? Diabetes Care Nov. 2009;32(Suppl 2):S378\u201383. https:\/\/doi.org\/10.2337\/dc09-S344.","journal-title":"Diabetes Care Nov"},{"key":"4424_CR21","doi-asserted-by":"publisher","unstructured":"Busuioc R, Stefan G, Stancu S, Zugravu A, Mircescu G. Nephrotic syndrome and Statin therapy: an outcome analysis. Medicina (Kaunas) Mar. 2023;6(3). https:\/\/doi.org\/10.3390\/medicina59030512.","DOI":"10.3390\/medicina59030512"},{"issue":"8","key":"4424_CR22","doi-asserted-by":"publisher","first-page":"e71817","DOI":"10.1371\/journal.pone.0071817","volume":"8","author":"CW Chen","year":"2013","unstructured":"Chen CW, Chen TC, Huang KY, Chou P, Chen PF, Lee CC. Differential impact of Statin on new-onset diabetes in different age groups: a population-based case-control study in women from an Asian country. PLoS ONE. 2013;8(8):e71817. https:\/\/doi.org\/10.1371\/journal.pone.0071817.","journal-title":"PLoS ONE"},{"key":"4424_CR23","unstructured":"Gwira JA, Fryar CD, Gu Q. Prevalence of total, diagnosed, and undiagnosed diabetes in adults: United States, August 2021-August 2023. NCHS Data Brief Nov. 2024;51610.15620\/cdc\/165794."},{"issue":"1","key":"4424_CR24","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1038\/s41467-021-24956-2","volume":"6","author":"L Grevendonk","year":"2021","unstructured":"Grevendonk L, Connell NJ, McCrum C, et al. Impact of aging and exercise on skeletal muscle mitochondrial capacity, energy metabolism, and physical function. Nat Commun Aug. 2021;6(1):4773. https:\/\/doi.org\/10.1038\/s41467-021-24956-2.","journal-title":"Nat Commun Aug"},{"issue":"10","key":"4424_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2213-8587(23)00225-5","volume":"11","author":"S Misra","year":"2023","unstructured":"Misra S, Ke C, Srinivasan S, et al. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol Oct. 2023;11(10):768\u201382. https:\/\/doi.org\/10.1016\/S2213-8587(23)00225-5.","journal-title":"Lancet Diabetes Endocrinol Oct"},{"issue":"3","key":"4424_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4093\/dmj.2022.0348","volume":"47","author":"B Wicklow","year":"2023","unstructured":"Wicklow B, Retnakaran R. Gestational diabetes mellitus and its implications across the life span. Diabetes Metab J May. 2023;47(3):333\u201344. https:\/\/doi.org\/10.4093\/dmj.2022.0348.","journal-title":"Diabetes Metab J May"},{"issue":"1","key":"4424_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","volume":"18","author":"WD Strain","year":"2018","unstructured":"Strain WD, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol Apr. 2018;18(1):57. https:\/\/doi.org\/10.1186\/s12933-018-0703-2.","journal-title":"Cardiovasc Diabetol Apr"},{"issue":"6","key":"4424_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","volume":"11","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol Jun. 2023;11(6):426\u201340. https:\/\/doi.org\/10.1016\/S2213-8587(23)00086-4.","journal-title":"Lancet Diabetes Endocrinol Jun"},{"key":"4424_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.2147\/DMSO.S330253","volume":"15","author":"P Shah","year":"2022","unstructured":"Shah P, Kalra S, Yadav Y, et al. Management of Glucocorticoid-Induced hyperglycemia. Diabetes Metab Syndr Obes. 2022;15:1577\u201388. https:\/\/doi.org\/10.2147\/DMSO.S330253.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"4424_CR30","doi-asserted-by":"publisher","unstructured":"Beaupere C, Liboz A, Feve B, Blondeau B, Guillemain G. Molecular mechanisms of Glucocorticoid-Induced insulin resistance. Int J Mol Sci Jan. 2021;9(2). https:\/\/doi.org\/10.3390\/ijms22020623.","DOI":"10.3390\/ijms22020623"},{"issue":"4S","key":"4424_CR31","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease. Improving global outcomes CKDWG. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Apr. 2024;105(4S):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int Apr"},{"issue":"1","key":"4424_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"1","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J Jan. 2020;1(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J Jan"},{"issue":"12","key":"4424_CR33","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1001\/jamainternmed.2021.5714","volume":"1","author":"IA Mansi","year":"2021","unstructured":"Mansi IA, Chansard M, Lingvay I, Zhang S, Halm EA, Alvarez CA. Association of Statin therapy initiation with diabetes progression: a retrospective matched-cohort study. JAMA Intern Med Dec. 2021;1(12):1562\u201374. https:\/\/doi.org\/10.1001\/jamainternmed.2021.5714.","journal-title":"JAMA Intern Med Dec"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04424-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04424-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04424-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T16:03:10Z","timestamp":1756224190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04424-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4424"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04424-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were approved by the Medical Ethics Committee of Wuhan Central Hospital (Approval No. WHZXKYL2022-112-01), Clinical trial number: not applicable. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki (2013). The study was conducted in accordance with local legislation and institutional requirements. Written informed consent was not required in accordance with national legislation and institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"490"}}